ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RNXT vs MNOV // FORWARD P/E MULTIPLE

RenovoRx Inc. (NASDAQ) VS. Medicinova Inc (NASDAQ) • 15-METRIC TALLY: RNXT 3 — MNOV 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RNXT VS. MNOV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RNXT MNOV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 70.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -16.32% -14.24% -2.08 MNOV /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% 68.00% -128.00 MNOV /net-margins <GO>
Revenue Growth (YoY) 180.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.40 0.20 +0.20 RNXT /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 RNXT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.1 38.4 +8.69 RNXT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — 5.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $67.2M $68.9M -$1.7M MNOV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RNXT REV MNOV REV RNXT GROSS % MNOV GROSS % RNXT FCF MNOV FCF
FY 2025 $1.1M $409.7K 70.9% — -$11.0M -$9.8M
FY 2024 $43.0K $0 98.0% — -$9.1M -$10.6M
FY 2023 $0 $1.0M — — -$10.3M -$7.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RNXT // BETA —
MNOV // BETA —